- Evonik’s ThreAMINO® contract manufacturer declares a force majeure event
- Shortage of supply affects all regions
- Limited stock of material available
Due to the Covid-19 virus outbreak, Evonik’s contract manufacturer had to shut-down its production facilities. Both production and shipping of the amino acid ThreAMINO® are affected.
Dr. Emmanuel Auer, Head of Animal Nutrition Business Line at Evonik, explained: “Regrettably, we are facing a supply shortage for ThreAMINO®. We have therefore decided to send a Force Majeure notification to our customers with immediate effect, in accordance with our contracts. Meanwhile, we try the utmost to mitigate this situation and re-establish supply to our customers as fast as possible.”
Evonik is keeping its customers regularly informed as the situation develops.